Moxifloxacino Tevagen

Moxifloxacin, the active ingredient in Moxifloxacino Tevagen, is a fluoroquinolone antibiotic presented as an oral dosage form for systemic use. It treats a range of serious bacterial infections in adults and children when prescribed by a qualified healthcare professional.

GNH USA supplies Moxifloxacino Tevagen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections affecting various organ systems.

- Community‑acquired bacterial pneumonia: eradicates susceptible pathogens, improving respiratory function and reducing fever. - Acute bacterial sinusitis: clears sinus infection, relieving congestion and facial pain. - Acute bacterial exacerbation of chronic bronchitis: reduces bacterial load, aiding recovery of lung function. - Skin and skin structure infections: eliminates causative bacteria, promoting wound healing. - Intra‑abdominal infections: treats mixed‑organism infections, supporting resolution of abdominal pain and systemic signs.

Moxifloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function, especially in the Achilles tendon. - QT interval prolongation: risk of cardiac arrhythmias. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Severe allergic reaction: anaphylaxis with swelling, breathing difficulty. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Peripheral neuropathy: tingling or numbness in extremities.

Before prescribing moxifloxacin, consider patient‑specific factors and safety measures.

- Pregnancy: category C; use only if potential benefits justify potential fetal risk. - Renal impairment: assess kidney function; dose adjustment may be required. - History of tendon disorders: avoid use due to increased risk of tendon rupture. - Concomitant QT‑prolonging drugs: monitor ECG and electrolytes closely. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Moxifloxacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce moxifloxacin absorption. - Corticosteroids: increase risk of tendon rupture. - Warfarin: may enhance anticoagulant effect, raising bleeding risk.

Moderate Interactions (Monitor Closely): - Theophylline: may increase serum theophylline concentrations. - Cyclosporine: may raise moxifloxacin plasma levels, requiring monitoring.